Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Tebaldi

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|November 10, 2017
Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based VectorAndrea Elizabeth Verna, Valentina Franceschi, Giulia Tebaldi, et al.
Journal of Translational Medicine|November 25, 2016
BoHV-4-based vector delivering Ebola virus surface glycoproteinAlfonso Rosamilia, Sarah Jacca, Giulia Tebaldi, et al.
Frontiers in Immunology|March 26, 2026
HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicityGiulia Tebaldi, Kevin P Egan, Lauren M Hook, et al.
Plos Neglected Tropical Diseases|June 19, 2015
BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal ChallengeValentina Franceschi, Scott Parker, Sarah Jacca, et al.
Viruses|July 29, 2023
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1Kevin P Egan, Sita Awasthi, Giulia Tebaldi, et al.
Frontiers in Immunology|January 11, 2020
Capacity to Elicit Cytotoxic CD8 T Cell Activity Against <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> Is Retained in a Vaccine Candidate 35 kDa Peptide Modified for Expression in Mammalian CellsValentina Franceschi, Asmaa H Mahmoud, Gaber S Abdellrazeq, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|November 10, 2017
Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based VectorAndrea Elizabeth Verna, Valentina Franceschi, Giulia Tebaldi, et al.
Journal of Translational Medicine|November 25, 2016
BoHV-4-based vector delivering Ebola virus surface glycoproteinAlfonso Rosamilia, Sarah Jacca, Giulia Tebaldi, et al.
Frontiers in Immunology|March 26, 2026
HSV-2 gE2/gI2 are immune evasion molecules that bind IgG Fc to inhibit antibody-dependent cellular cytotoxicityGiulia Tebaldi, Kevin P Egan, Lauren M Hook, et al.
Plos Neglected Tropical Diseases|June 19, 2015
BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal ChallengeValentina Franceschi, Scott Parker, Sarah Jacca, et al.
Viruses|July 29, 2023
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1Kevin P Egan, Sita Awasthi, Giulia Tebaldi, et al.
Frontiers in Immunology|January 11, 2020
Capacity to Elicit Cytotoxic CD8 T Cell Activity Against <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> Is Retained in a Vaccine Candidate 35 kDa Peptide Modified for Expression in Mammalian CellsValentina Franceschi, Asmaa H Mahmoud, Gaber S Abdellrazeq, et al.
Pageof 2